Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Price:
5.29 USD
1.54%
Market Closed
Updated:
May 29, 2024
Aurinia Pharmaceuticals Inc
Other Current Assets
|
Aurinia Pharmaceuticals Inc
Other Current Assets Peer Comparison
Comparables:
ZYME
TH
RPTX
FUSN
EDT
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Other Current Assets
$10.2m
|
CAGR 3-Years
14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
59%
|
|
|
Zymeworks Inc
NYSE:ZYME
|
Other Current Assets
$19.1m
|
CAGR 3-Years
13%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
|
Theratechnologies Inc
TSX:TH
|
Other Current Assets
$2.7m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
18%
|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Other Current Assets
$4.7m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
74%
|
CAGR 10-Years
N/A
|
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Other Current Assets
$4.3m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Spectral Medical Inc
TSX:EDT
|
Other Current Assets
CA$980k
|
CAGR 3-Years
14%
|
CAGR 5-Years
15%
|
CAGR 10-Years
11%
|
See Also
What is Aurinia Pharmaceuticals Inc's Other Current Assets?
Other Current Assets
10.2m
USD
10.2m
USD
Based on the financial report for Mar 31, 2024, Aurinia Pharmaceuticals Inc's Other Current Assets amounts to 10.2m USD.
What is Aurinia Pharmaceuticals Inc's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
59%
59%
Over the last year, the Other Current Assets growth was -10%. The average annual Other Current Assets growth rates for Aurinia Pharmaceuticals Inc have been 14% over the past three years , 9% over the past five years , and 59% over the past ten years .
You don't have any saved screeners yet
